Jason Cosgrove
Indianapolis, INNPI 1598976649
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations.
Across 127 payments — averaging $17.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$334
- Merck$302
- Corium, LLC$263
- Pfizer$246
- Supernus Pharmaceuticals, Inc.$176
- Sanofi Pasteur Inc.$160
- plus $740 from 14 others
What the payments were for
- Food & beverage$2,220100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 23 | $334 |
| Merck | 11 | $302 |
| Corium, LLC | 15 | $263 |
| Pfizer | 16 | $246 |
| Supernus Pharmaceuticals, Inc. | 8 | $176 |
| Sanofi Pasteur Inc. | 8 | $160 |
| Tris Pharma Inc | 10 | $149 |
| AstraZeneca | 4 | $82 |
| Collegium Pharmaceutical, Inc. | 5 | $76 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| Adlon Therapeutics L.p. | 5 | $61 |
| Shire North American Group Inc | 3 | $54 |
| Sanofi-aventis U.S. LLC | 2 | $46 |
| Neos Therapeutics, LP | 3 | $44 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Kaleo, Inc. | 2 | $26 |
| Seqirus USA Inc | 1 | $18 |
| GSK | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GARDASIL$117
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.